Based on 9 analysts giving stock ratings to aTyr Pharma Inc in the past month.
In the current month, ATYR has received 3 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. ATYR average Analyst price target in the last month is 113.333.
Based on analysts' estimates, ATYR EPS is projected to reach -6.537 in FY2026Q4, following reported EPS of -7.433 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -7.43, while aTyr Pharma IncATYR's earnings per share (EPS) for the previous quarter was USD -4.20. EPS for the next quarter is expected at USD -6.54.